Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
24%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
GNMX
56
HOLDINGS
16%
ALSO IN PBE
PBE
33
HOLDINGS
31%
ALSO IN GNMX
SECTOR DRIFT (GNMX minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNMX |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 6.7% | 5.0% | 5.0% | |
| ALNYLAM PHARMACEUTICALS INC | 3.6% | 4.6% | 3.6% | |
| ILLUMINA INC | 4.3% | 3.0% | 3.0% | |
| INCYTE CORP | 3.3% | 2.7% | 2.7% | |
| BIO-TECHNE CORPORATION | 2.6% | 3.2% | 2.6% | |
GNMX Overweight Relative to PBE
| THERMO FISHER SCIENTIFIC INC | 9.1% | |
| REVOLUTION MEDICINES, INC. | 3.9% | |
| GUARDANT HEALTH, INC. | 3.8% | |
| MODERNA, INC. | 3.0% | |
| GENMAB A/S SPONSORED ADR | 2.9% | |
| 10X GENOMICS INC CLASS A | 2.5% | |
| ARROWHEAD PHARMACEUTICALS, INC. | 2.3% | |
| KRYSTAL BIOTECH, INC. | 2.2% | |
| QIAGEN NV | 2.1% | |
| TWIST BIOSCIENCE CORP. | 1.9% |
GNMX Underweight Relative to PBE
| BIOGEN IDEC INC | -4.9% | |
| AMGEN INC | -4.9% | |
| ROYALTY PHARMA PLC CLASS A | -4.8% | |
| REGENERON PHARMACEUTICALS | -4.7% | |
| UNITED THERAPEUTICS CORP | -4.5% | |
| GILEAD SCIENCES INC | -4.5% | |
| PTC THERAPEUTICS INC | -3.1% | |
| VERICEL CORPORATION | -3.0% | |
| REPLIGEN CORP | -3.0% | |
| PROTAGONIST THERAPEUTICS, INC. | -3.0% |